HPGC Renmintongtai Pharmaceutical Corp (600829) — Working Capital to Net Assets Ratio
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Working Capital to Net Assets ratio of 88.8% as of March 2026. Working capital of CN¥2.72 Billion (current assets of CN¥6.87 Billion minus current liabilities of CN¥4.15 Billion) is measured against net assets of CN¥3.06 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See HPGC Renmintongtai Pharmaceutical Corp balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
HPGC Renmintongtai Pharmaceutical Corp Working Capital to Net Assets (1994–2025)
This chart shows how HPGC Renmintongtai Pharmaceutical Corp's Working Capital to Net Assets ratio has evolved across 32 annual periods from 1994 to 2025. As of March 2026, the ratio stands at 88.8%, reflecting working capital of CN¥2.72 Billion against net assets of CN¥3.06 Billion CNY. Check HPGC Renmintongtai Pharmaceutical Corp tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for HPGC Renmintongtai Pharmaceutical Corp (1994–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for HPGC Renmintongtai Pharmaceutical Corp from 1994 to 2025, covering 32 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see HPGC Renmintongtai Pharmaceutical Corp market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 88.8% | CN¥2.68 Billion | CN¥3.01 Billion | CN¥6.69 Billion | CN¥4.01 Billion | ▲ +0.2 pp |
| 2024 | 88.6% | CN¥2.55 Billion | CN¥2.88 Billion | CN¥6.69 Billion | CN¥4.13 Billion | ▲ +1.2 pp |
| 2023 | 87.4% | CN¥2.40 Billion | CN¥2.75 Billion | CN¥6.92 Billion | CN¥4.52 Billion | ▲ +1.5 pp |
| 2022 | 85.9% | CN¥2.12 Billion | CN¥2.46 Billion | CN¥6.55 Billion | CN¥4.43 Billion | ▲ +2.7 pp |
| 2021 | 83.1% | CN¥1.83 Billion | CN¥2.20 Billion | CN¥6.19 Billion | CN¥4.36 Billion | ▼ -0.8 pp |
| 2020 | 84.0% | CN¥1.67 Billion | CN¥1.99 Billion | CN¥5.54 Billion | CN¥3.86 Billion | ▲ +2.1 pp |
| 2019 | 81.9% | CN¥1.51 Billion | CN¥1.85 Billion | CN¥5.07 Billion | CN¥3.56 Billion | ▲ +3.6 pp |
| 2018 | 78.3% | CN¥1.24 Billion | CN¥1.58 Billion | CN¥3.92 Billion | CN¥2.69 Billion | ▲ +1.4 pp |
| 2017 | 76.9% | CN¥1.24 Billion | CN¥1.61 Billion | CN¥4.32 Billion | CN¥3.08 Billion | ▼ -1.2 pp |
| 2016 | 78.1% | CN¥1.29 Billion | CN¥1.65 Billion | CN¥4.26 Billion | CN¥2.98 Billion | ▲ +5.2 pp |
| 2015 | 72.9% | CN¥1.04 Billion | CN¥1.42 Billion | CN¥3.68 Billion | CN¥2.65 Billion | ▲ +29.1 pp |
| 2014 | 43.7% | CN¥941.39 Million | CN¥2.15 Billion | CN¥1.99 Billion | CN¥1.05 Billion | ▲ +2.4 pp |
| 2013 | 41.3% | CN¥932.95 Million | CN¥2.26 Billion | CN¥2.32 Billion | CN¥1.39 Billion | ▼ -2.0 pp |
| 2012 | 43.4% | CN¥1.00 Billion | CN¥2.31 Billion | CN¥2.68 Billion | CN¥1.68 Billion | ▲ +9.1 pp |
| 2011 | 34.2% | CN¥662.57 Million | CN¥1.94 Billion | CN¥2.50 Billion | CN¥1.84 Billion | ▲ +1.4 pp |
| 2010 | 32.8% | CN¥571.12 Million | CN¥1.74 Billion | CN¥2.09 Billion | CN¥1.52 Billion | ▼ -3.8 pp |
| 2009 | 36.6% | CN¥606.34 Million | CN¥1.66 Billion | CN¥1.72 Billion | CN¥1.11 Billion | ▼ -2.2 pp |
| 2008 | 38.8% | CN¥638.97 Million | CN¥1.65 Billion | CN¥1.88 Billion | CN¥1.24 Billion | ▲ +4.2 pp |
| 2007 | 34.5% | CN¥485.12 Million | CN¥1.41 Billion | CN¥1.73 Billion | CN¥1.24 Billion | ▲ +0.4 pp |
| 2006 | 34.1% | CN¥369.56 Million | CN¥1.08 Billion | CN¥1.40 Billion | CN¥1.03 Billion | ▼ -3.4 pp |
| 2005 | 37.5% | CN¥333.51 Million | CN¥888.23 Million | CN¥1.25 Billion | CN¥916.05 Million | ▲ +11.5 pp |
| 2004 | 26.1% | CN¥271.14 Million | CN¥1.04 Billion | CN¥965.71 Million | CN¥694.57 Million | ▲ +27.4 pp |
| 2003 | -1.4% | CN¥-7.68 Million | CN¥560.39 Million | CN¥346.54 Million | CN¥354.22 Million | ▼ -12.1 pp |
| 2002 | 10.7% | CN¥56.56 Million | CN¥526.17 Million | CN¥381.29 Million | CN¥324.73 Million | ▲ +0.5 pp |
| 2001 | 10.2% | CN¥51.29 Million | CN¥501.11 Million | CN¥414.14 Million | CN¥362.84 Million | ▼ -22.2 pp |
| 2000 | 32.5% | CN¥151.42 Million | CN¥466.36 Million | CN¥543.96 Million | CN¥392.54 Million | ▲ +8.1 pp |
| 1999 | 24.4% | CN¥102.79 Million | CN¥422.13 Million | CN¥359.88 Million | CN¥257.09 Million | ▲ +6.8 pp |
| 1998 | 17.5% | CN¥75.41 Million | CN¥430.69 Million | CN¥308.64 Million | CN¥233.23 Million | ▼ -4.5 pp |
| 1997 | 22.0% | CN¥93.82 Million | CN¥426.02 Million | CN¥308.87 Million | CN¥215.04 Million | ▲ +12.8 pp |
| 1996 | 9.2% | CN¥38.18 Million | CN¥413.92 Million | CN¥233.75 Million | CN¥195.57 Million | ▼ -4.2 pp |
| 1995 | 13.5% | CN¥55.21 Million | CN¥409.86 Million | CN¥245.36 Million | CN¥190.16 Million | ▼ -16.4 pp |
| 1994 | 29.9% | CN¥121.46 Million | CN¥406.37 Million | CN¥243.62 Million | CN¥122.16 Million | — |